Hallway Conversations is a series of audio podcasts with thought leaders and newsmakers in the field of epilepsy on a range of seizure related topics. The series covers a range of topics and are intended to address a wide range of audiences.

We hope that you find the series informative and helpful and that you join us in listening on a regular basis.

 Dr. Joseph Sirven, Editor-in-Chief

AAN taskforce for developing epilepsy quality measures

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Nathan Fountain, MD from the University of Virginia. Dr. Fountain will speak about his role as co-chair of the American Academy of Neurology taskforce for developing epilepsy quality measures. There are 8 new proposed quality measures that are now open for public comment. This is a live taping with no questions to be answered live.

Generic versus Brand Seizure Medications

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Jacqueline French of New York University School of Medicine. Dr. French, an internationally renowned epilepsy specialist will speak about the issues surrounding the use of generic seizure medications. This is a live taping with no questions to be answered live.

Rufinamide

Recently, the US Federal Drug Administration (FDA) approved a new medication for seizures and epilepsy, Rufinamide. Rufinamide will soon be available for us in the US. In this episode of Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Greg Krauss an international renowned epilepsy specialist from Johns Hopkins University. This show will be taped live but no questions will be answered live on the air.

Vigabatrin and infantile spasms

Recently, the US Federal Drug Administration (FDA) approved a new medication for seizures and epilepsy, Vigabatrin. Vigabatrin will soon be available for us in the US with one of it indications being infantile spasms. The question is what are infantile spasms and what can you do for seizures in the very young? In this episode of Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Elaine Wirrell, an internationally renowned epilepsy specialist from Mayo Clinic Rochester. This show will be taped live but no questions will be answered live on the air.

New Treatments for Seizures: Focus on Lacosamide

Recently, the US Federal Drug Administration (FDA) approved a new medication for seizures and epilepsy, Lacosamide. Lacosamide will soon be available for us in the US. In this episode of Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Elinor Ben-Menachem an international renowned epilepsy specialist from University of Gothenberg, Gothenberg, Sweden. This show will be taped live but no questions will be answered live on the air.

Pages